These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36271137)

  • 21. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
    Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of progestin-primed ovarian stimulation (PPOS) versus minimal stimulation in women of advanced maternal age with poor ovarian response under the Patient-Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) criteria.
    Zhao S; Wang C
    Ann Palliat Med; 2023 Jan; 12(1):133-140. PubMed ID: 36747387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
    Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
    J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
    Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
    Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live birth rates of low prognosis patients according to POSEIDON criteria; A retrospective cohort study.
    Seven B; Gulerman C; Ozgu-Erdinc AS; Yilmaz N; Engin-Ustun Y
    J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101817. PubMed ID: 32428781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular Output Rate and Follicle-to-Oocyte Index of Low Prognosis Patients According to POSEIDON Criteria: A Retrospective Cohort Study of 32,128 Treatment Cycles.
    Chen L; Wang H; Zhou H; Bai H; Wang T; Shi W; Shi J
    Front Endocrinol (Lausanne); 2020; 11():181. PubMed ID: 32318023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of Endometrioma Does Not Impair Embryo Quality and Assisted Reproductive Technology (ART) Cycle Outcome in Diminished Ovarian Reserve (DOR) Patients.
    Osmanlıoğlu Ş; Berker B; Aslan B; Şükür YE; Özmen B; Sönmezer M; Atabekoğlu CS; Aytaç R
    Reprod Sci; 2023 May; 30(5):1540-1547. PubMed ID: 36303087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines.
    Esteves SC; Conforti A; Sunkara SK; Carbone L; Picarelli S; Vaiarelli A; Cimadomo D; Rienzi L; Ubaldi FM; Zullo F; Andersen CY; Orvieto R; Humaidan P; Alviggi C
    Front Endocrinol (Lausanne); 2021; 12():587051. PubMed ID: 33815269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. POSEIDON classification and the proposed treatment options for groups 1 and 2: time to revisit? A retrospective analysis of 1425 ART cycles.
    Chinta P; Antonisamy B; Mangalaraj AM; Kunjummen AT; Kamath MS
    Hum Reprod Open; 2021; 2021(1):hoaa070. PubMed ID: 33614989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal and neonatal complications after IVF/ICSI-fresh embryo transfer in low-prognosis women under the POSEIDON criteria: a retrospective cohort study.
    Li S; Tan H; Fu H; Du J; Liu P; Qin Y
    BMC Pregnancy Childbirth; 2023 Dec; 23(1):855. PubMed ID: 38087253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study.
    Lee KS; Lin MH; Hwu YM; Yang JH; Lee RK
    J Ovarian Res; 2023 Mar; 16(1):49. PubMed ID: 36869354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Euploid blastocyst rates in patients from POSEIDON groups 3 and 4 using propensity score matching.
    Liu L; Cai B; Zhang X; Huang J; Zhou C
    Reprod Biomed Online; 2022 Aug; 45(2):374-383. PubMed ID: 35654685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.
    Xu Y; Nisenblat V; Lu C; Li R; Qiao J; Zhen X; Wang S
    Reprod Biol Endocrinol; 2018 Mar; 16(1):29. PubMed ID: 29587861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis.
    Yang R; Zhang C; Chen L; Wang Y; Li R; Liu P; Qiao J
    Reprod Biomed Online; 2020 Nov; 41(5):834-844. PubMed ID: 32978073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of time of recombinant luteinized hormone supplementation on pregnancy outcomes of women with advanced reproductive age during follicular-phase long protocol].
    Wang L; Wang J; Hu YQ; Liu JY; Diao FY
    Zhonghua Fu Chan Ke Za Zhi; 2022 Oct; 57(10):758-766. PubMed ID: 36299179
    [No Abstract]   [Full Text] [Related]  

  • 37. An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria.
    Levi-Setti PE; Zerbetto I; Baggiani A; Zannoni E; Sacchi L; Smeraldi A; Morenghi E; De Cesare R; Drovanti A; Santi D
    Front Endocrinol (Lausanne); 2019; 10():282. PubMed ID: 31139146
    [No Abstract]   [Full Text] [Related]  

  • 38. Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: A retrospective cohort study.
    Chern CU; Li JY; Tsui KH; Wang PH; Wen ZH; Lin LT
    PLoS One; 2020; 15(7):e0235707. PubMed ID: 32628729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of blood groups with ovarian reserve and outcome of in vitro fertilization treatment.
    Awartani K; Al Ghabshi R; Al Shankiti H; Al Dossari M; Coskun S
    Ann Saudi Med; 2016; 36(2):116-20. PubMed ID: 27031784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live birth rates in different subgroups of poor ovarian responders according to Bologna and POSEIDON group classification criteria.
    Mashayekhi M; Barabi F; Arabipoor A; Zolfaghari Z
    J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102169. PubMed ID: 34044136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.